06990.HK
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 437.80
+0.97%Margins
Gross margin
74.6%
EBITDA margin
3.7%
EBIT margin
2.5%
Net margin
5.8%
FCF margin
19.6%
2.4%
Return on equity
2.0%
Return on assets
1.0%
Return on invested capital
0.35x
Asset turnover
HKD 648.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026